- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2020–2023 · career development · K23
Determining Mechanisms and Measures for the Design of Chemotherapy-Induced Peripheral Neuropathy Clinical Trials in Adolescents and Young Adults with Cancer
Robert James Knoerl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2026 · research · R00
Deep clinical trajectory modeling to optimize accrual to cancer clinical trials
Kenneth L Kehl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · career development · K08
Regulating proliferation and differentiation of erythroid progenitors
Hojun Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R00
Interrogating and rewiring cell signaling pathways in CAR-T cells with synthetic phosphotyrosine recognition domains
Xin Zhou · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Comprehensive genomic profiling of aggressive hormone sensitive prostate cancer
Christopher J Sweeney · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
Martin E Hemler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · career development · K22
Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma
Catherine Marinac · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
William C. Hahn · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2022 · career development · K08
Defining clinically relevant transcriptional networks in gastrointestinal stromal tumor
Matthew Hemming · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · fellowship · F32
Defining IKZF1/IKAROS as an oncogene and therapeutic target in MLL-r AML
Jevon Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
Martin E Hemler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2022 · fellowship · F32
Remodeling mitochondrial cristae to rescue bioenergetic defects in mitochondrial disease
Beste Mutlu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Mouse models of Kras-mutant colorectal cancer
Kevin Haigis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · program · P01
New therapeutic vulnerabilities in breast cancer
Kornelia Polyak · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2026 · research · R01
Next Generation Computational Tools for Functional Genomics
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
Cloud Peter Paweletz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing the LINE-1 Retrotransposition-Replication Conflict
Kathleen H Burns · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
William C. Hahn · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Engagement with healthcare system, tobacco use and cancer communication during COVID-19 in India - Administrative Supplement to Project LifeFirst SWASTH
Shoba Ramanadhan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Next Generation Computational Tools for Functional Genomics
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
NMR Fingerprinting: Leveraging optimal control pulse design, tailored isotope labeling, and machine learning to study intractable proteins
Haribabu Arthanari · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R00
De novo design of small-molecule-binding proteins
Nicholas Polizzi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · research · Basic
Harnessing immune privilege mechanisms from stem cells to protect beta-cells from immune attack
Judith Agudo · Dana-Farber Cancer Institute · funded by American Diabetes Association
2020 · career development · Young Investigator Award
Tracing clonal evolution of chronic lymphocytic leukemia to Richter's transformation
Erin Parry · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · career development · Young Investigator Award
Targeting Activated Signaling by ERK Inhibition in Acute Myeloid Leukemia
Rahul Vedula · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · career development · Young Investigator Award
Dissecting the tumor-intrinsic and immune drivers of selective response to combination therapies in NSCLC
Natalie Vokes · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · career development · Young Investigator Award
Impact of DNA damage repair (DDR) gene mutations on efficacy of PD-(L)1 immune checkpoint inhibition in non-small cell lung cancer
Biagio Ricciuti · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · career development · Young Investigator Award
Epigenomic and Functional Analysis of Testicular Germ Cell Tumors
Alok Tewari · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · career development · Young Investigator Award
Development of a PD-1 bispecific that enhances anti-tumor immunity and alleviates autoimmunity
James Torchia · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · career development · Career Development Award
A phase II clinical trial investigating the clinical and immunologic activity of margetuximab, a novel anti-HER2 antibody therapy, in early-stage HER2-positive breast cancer
Adrienne Waks · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020–2024 · research · SU2C CANADA – LUSTGARTEN FOUNDATION – PANCREATIC CANCER CANADA PASS CONVERGENCE DREAM TEAM
PASS-01- Pancreatic Adenocarcinoma Signature Stratification for Treatment-01
Jennifer Knox · Dana-Farber Cancer Institute · funded by Stand Up To Cancer Canada
2020 · career development · Career Development Award
Plasma genotyping-based response assessment to guide adaptive treatment of advanced non-small cell lung cancer (NSCLC) receiving immunotherapy
Michael Cheng · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · fellowship · AACR-Incyte Immuno-oncology Research Fellowship
Addressing AML with vaccine-induced polyclonal leukemia-specific T cells
Nicoletta Cieri · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2020 · fellowship · ASH Research Training Award for Fellows (RTAF): First Year Awardees
ASH Research Training Award for Fellows (RTAF) 2020: Kirsty Hillier
Kirsty Hillier · Dana-Farber Cancer Institute · funded by American Society of Hematology
2020 · career development · Young Investigator Award
Advancing WRN as a synthetic lethal target for microsatellite unstable cancers
Edmond Chan · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · research · AACR-MPM Oncology Charitable Foundation Transformative Research Grant
Bivalent DUB recruiters for targeted protein stabilization
Sara J. Buhrlage · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2020 · research · Breast Cancer Research Foundation-AACR Career Development Awards for Translational Breast Cancer Research
Overcoming residual disease in HER2+ breast cancer
Sheheryar Kabraji · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2020 · career development · Young Investigator Award
Dissecting the Immunogenomics of Immune Checkpoint Inhibitor Response and Resistance in Glioblastomas
Julian Iorgulescu · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2020 · career development · Career Development Award
Evaluation of circulating tumor DNA (ctDNA) as a biomarker to inform novel treatment strategies for patients with Ewing sarcoma and osteosarcoma
David Shulman · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
